Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View

SIMPLE SUMMARY: Hepatocellular carcinoma is the second most common cause of cancer-related deaths and accounts for over eighty percent of primary liver cancers worldwide. Regarding the Milan Criteria, only a small portion of HCC patients are eligible for liver transplantation due to advanced-stage d...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelrahim, Maen, Esmail, Abdullah, Saharia, Ashish, Abudayyeh, Ala, Abdel-Wahab, Noha, Diab, Adi, Murakami, Naoka, Kaseb, Ahmed O., Chang, Jenny C., Gaber, Ahmed Osama, Ghobrial, Rafik Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997123/
https://www.ncbi.nlm.nih.gov/pubmed/35406533
http://dx.doi.org/10.3390/cancers14071760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997123/
https://www.ncbi.nlm.nih.gov/pubmed/35406533
http://dx.doi.org/10.3390/cancers14071760

Ejemplares similares